Table 2.
Number of patients | 147 |
Median age at diagnosis (range) | 36.7 (18–64) |
Male:female ratio | 1.2:1 |
Histologic grade (%) | |
WHO grade II | 81 (55.1) |
WHO grade III | 66 (44.9) |
Molecular diagnosis (%) | |
Astrocytic | 95 (64.6) |
Oligodendroglial | 52 (35.4) |
Median follow-up | |
Non-progressors | 4.1 y |
Survivors | 4.0 y |